Vascular endothelial growth factor-B gene transfer exacerbates retinal and choroidal neovascularization and vasopermeability without promoting inflammation
2011

VEGF-B Gene Transfer Increases Retinal and Choroidal Neovascularization

Sample size: 10 publication Evidence: moderate

Author Information

Author(s): Zhong Xiufeng, Huang Hu, Shen Jikui, Zacchigna Serena, Zentilin Lorena, Giacca Mauro, Vinores Stanley A.

Primary Institution: Wilmer Eye Institute, Johns Hopkins University School of Medicine

Hypothesis

The study evaluates the effect of overexpression of VEGF-B via gene transfer on ocular angiogenesis, inflammation, and the blood-retinal barrier.

Conclusion

VEGF-B overexpression promotes pathological retinal and choroidal neovascularization and blood-retinal barrier breakdown without causing inflammation.

Supporting Evidence

  • VEGF-B167 and VEGF-B186 increased retinal and choroidal neovascularization.
  • VEGF-B186 significantly increased retinal vascular permeability.
  • There was no evidence of an inflammatory response following the gene transfer.
  • VEGF-B targeting could benefit antiangiogenic therapy.

Takeaway

The study found that increasing a protein called VEGF-B in the eye can lead to more abnormal blood vessel growth without causing inflammation, which is important for understanding eye diseases.

Methodology

The study used adeno-associated virus vectors to deliver VEGF-B genes to mice and assessed the effects on neovascularization and blood-retinal barrier integrity.

Participant Demographics

C57BL/6 mice were used in the study.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication